Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
322.83
+4.58 (1.44%)
Jun 27, 2025, 4:00 PM - Market closed
Alnylam Pharmaceuticals Analyst Ratings
Total Analysts
24
Consensus Rating
Strong Buy
Price Target
$335.74
Upside
+4.00%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $320 → $377 | Strong Buy | Maintains | $320 → $377 | +16.78% | Jun 26, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $300 → $360 | Buy | Maintains | $300 → $360 | +11.51% | Jun 24, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $330 → $338 | Buy | Maintains | $330 → $338 | +4.70% | Jun 12, 2025 |
| UBS | UBS | Strong Buy Maintains $331 → $349 | Strong Buy | Maintains | $331 → $349 | +8.11% | May 2, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $300 → $325 | Strong Buy | Maintains | $300 → $325 | +0.67% | May 2, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $284 → $268 | Hold | Maintains | $284 → $268 | -16.98% | Apr 11, 2025 |
| Needham | Needham | Strong Buy Reiterates $320 | Strong Buy | Reiterates | $320 | -0.88% | Apr 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $500 | Strong Buy | Reiterates | $500 | +54.88% | Apr 2, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $338 → $342 | Buy | Maintains | $338 → $342 | +5.94% | Mar 31, 2025 |
| Redburn Atlantic | Redburn Atlantic | Strong Buy Initiates $353 | Strong Buy | Initiates | $353 | +9.35% | Mar 31, 2025 |
| Stifel | Stifel | Strong Buy Maintains $300 → $345 | Strong Buy | Maintains | $300 → $345 | +6.87% | Mar 31, 2025 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $280 → $328 | Hold → Buy | Upgrades | $280 → $328 | +1.60% | Mar 24, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $338 → $351 | Strong Buy | Maintains | $338 → $351 | +8.73% | Mar 21, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $385 → $390 | Strong Buy | Maintains | $385 → $390 | +20.81% | Mar 21, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $310 → $330 | Buy | Maintains | $310 → $330 | +2.22% | Mar 21, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $300 → $338 | Buy | Maintains | $300 → $338 | +4.70% | Mar 21, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.